Osteoporosis treated with magnesium lactate.

Area of Science:

• Gerontology
• Endocrinology
• Pharmacology

Background:

• Osteoporosis is a significant health concern, particularly in senile and postmenopausal women.
• Medicamentous osteoporosis, often induced by corticosteroids, presents unique treatment challenges.

Purpose of the Study:

• To evaluate the efficacy of magnesium lactate monotherapy versus combination therapy with sodium fluoride in treating different types of osteoporosis.
• To assess the long-term effects of these treatments on pain, spinal mobility, kyphosis, and radiographic findings.

Main Methods:

• A study involving 60 patients with senile, postmenopausal, and medicamentous osteoporosis.
• Patients received either single magnesium lactate therapy or a combined magnesium lactate and sodium fluoride regimen.
• Treatment outcomes were evaluated over two years with assessments at six-month intervals.

Main Results:

• Single-agent magnesium lactate therapy demonstrated superior outcomes compared to the combined therapy.
• Treatments were more effective in patients with senile and postmenopausal osteoporosis than in those with medicamentous osteoporosis.
• Favorable improvements were observed in pain reduction and spinal movement, with stabilization of kyphosis and radiographic evidence.

Conclusions:

• Magnesium lactate monotherapy is a promising treatment for osteoporosis, offering benefits in pain and mobility.
• The efficacy of magnesium lactate may vary depending on the type of osteoporosis, with better responses in non-medicamentous forms.
• Further research could explore optimal dosing and patient selection for magnesium lactate treatment.